Project Grant HT94252510986
- The Department of the Army Medical Command awarded Baylor Research Institute a $4.48 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of September 15, 2021 to September 14, 2025. The grant will support Baylor Research Institute's "DOSING OF OVERGROUND ROBOTIC GAIT TRAINING WITH FUNCTIONAL OUTCOMES AND NEUROPLASTICITY AFTER SPINAL CORD INJURY" project located in Dallas, Texas. This project aims to investigate medical...
- This $1,499,872 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Results Group, LLC, a small disadvantaged business specializing in advanced assistive technologies and rehabilitation devices. The grant supports the development of an exoskeleton-integrated boot system to facilitate longer-term rehabilitation and return to duty for military personnel recovering from lateral ankle sprains. The innovative solution...
- The Defense Health Agency awarded a $1,401,588 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Roam Robotics Inc. to develop a unilateral powered knee orthosis for knee pain and instability intervention with the VA population. The award period runs from August 1, 2024 to January 31, 2026. Roam Robotics, a for-profit company that provides wearable robotics technologies, will leverage its expertise in exoskeleton systems and active knee assistance devices...
- This Project Grant award, funded by the National Science Foundation's Engineering program (CFDA 47.041), supports research to advance the understanding of how people learn to walk more efficiently with wearable robotic exoskeletons. The goal is to develop gait-assistive exoskeletons that not only adapt their mechanical assistance to the user, but also actively coach the user to work with the device for improved walking efficiency. The research team will conduct experiments to develop new metrics...
- This $100,000 federal Project Grant award from the National Institute on Disability, Independent Living, and Rehabilitation Research (CFDA 93.433) supports the development of innovative exoskeleton technologies as next-generation alternatives to traditional ankle-foot orthoses (AFOs) for adolescents with Charcot-Marie-Tooth (CMT) disease. The awardee, Results Group, LLC, is a small disadvantaged business focused on advanced assistive technologies and rehabilitation devices. Through this grant,...
- The U.S. Defense Health Agency awarded a $325,142 Project Grant to Onward Medical Inc. under the Military Medical Research and Development program (CFDA 12.420) to develop a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The grant period runs from September 1, 2025 to August 31, 2028. This project aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions...
- The University of Texas at Austin was awarded a $1,499,767 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate the impact of personalized robotic leg prostheses for individuals with transfemoral amputations of varying mobility levels. The research will be conducted from September 2022 through September 2026. A subaward of $150,000 was provided to the Georgia Tech Research Corporation to support...
- This $2,477,715.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support research conducted by the Regents of the University of Michigan to develop an exoskeleton control system using a muscle cuff regenerative peripheral nerve interface (MC-RPNI) for restoring lower limb function following traumatic musculoskeletal injury. The research aims to transform healthcare for military service members and the broader...
- The Defense Health Agency awarded a $490,602 Project Grant titled "CLINICAL-GRADE SPINAL CORD NEUROPROSTHESIS TO ALLEVIATE LOCOMOTOR DEFICITS IN PEOPLE WITH PARKINSON'S DISEASE" to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland. The grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports EPFL's advanced biomedical research to develop a neuroprosthetic system to help manage locomotor deficits associated with Parkinson's...
- The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $777,538.00 to the Baylor Research Institute in Dallas, TX to develop a "WALKING WITH OVERGROUND ROBOTIC EXOSKELETON DEVICE TO INCREASE BEHAVIORAL RESPONSIVENESS IN PATIENTS WITH DISORDERS OF CONSCIOUSNESS". The 3-year project, running from November 1, 2025 to October 31, 2028, aims to advance rehabilitation solutions for patients with disorders of consciousness through the use of an overground robotic exoskeleton device. The Baylor Research Institute, an experienced medical research organization, will lead the development and evaluation of this innovative technology to improve mobility and behavioral response in this patient population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $777.5k | 8/26/25 |